SCHEMBL29566968

SCHEMBL29566968

CCC(C)c1ccccc1Oc1cc(Oc2ccc(N3CCNCC3)cc2)nc(NS(=O)(=O)c2cnn(C)c2)n1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ HTR6 P50406 5/20 0.41
▸ HTR1A P08908 5/20 0.41
▸ HTR7 P34969 5/20 0.41
▸ DRD2 P14416 2/20 0.41
▸ RIPK2 O43353 3/20 0.38
▸ ACVR1 Q04771 3/20 0.38
▸ NOD2 Q9HC29 3/20 0.38
▸ FLT3 P36888 1/20 0.36
▸ GUSB P08236 2/20 0.35
▸ LTA4H P09960 1/20 0.35
▸ HTR2A P28223 1/20 0.35
▸ ALOX12 P18054 1/20 0.35
▸ BRD4 O60885 1/20 0.34
▸ LCK P06239 1/20 0.34
▸ JAK3 P52333 1/20 0.34
▸ BTK Q06187 1/20 0.34
▸ TNK2 Q07912 1/20 0.34
▸ MAPK8 P45983 1/20 0.34
▸ MAPK10 P53779 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24309746 1.00 HTR6 (0.41) HTR6HTR1AHTR7DRD2RIPK2
SCHEMBL26807773 0.88 RIPK2 (0.43) HTR6HTR7RIPK2ACVR1NOD2
SCHEMBL26807780 0.88 LTA4H (0.47) HTR6RIPK2ACVR1NOD2FLT3
SCHEMBL26807751 0.87 GUSB (0.41) HTR6HTR1ARIPK2ACVR1NOD2
SCHEMBL24309732 0.85 LTA4H (0.35) RIPK2ACVR1NOD2FLT3GUSB
SCHEMBL26808355 0.85 HTR6 (0.39) HTR6HTR1AHTR7DRD2RIPK2
SCHEMBL26807788 0.85 MAPK10 (0.47) HTR6HTR1ARIPK2ACVR1NOD2
SCHEMBL26807778 0.84 HTR3E (0.46) HTR6HTR1AHTR7RIPK2ACVR1
SCHEMBL29566834 0.84 HTR6 (0.38) HTR6HTR1AHTR7DRD2RIPK2
SCHEMBL26807343 0.84 HTR6 (0.38) HTR6HTR1AHTR7DRD2RIPK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225748-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback